News
SALT LAKE CITY, July 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today launched Valence Labs at ...
PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading ...
Recursion Pharmaceuticals has announced a research agreement with Sanofi Genzyme, to deploy its drug repurposing platform to identify new uses for Sanofi’s clinical stage molecules across dozens of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback